Stefano Taverna Selected Research

Stefano Taverna Research Topics

3	Nervous System Diseases (Neurological Disorders) 01/2019 - 07/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 10/2016
2	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 05/2020 - 10/2016
2	Epilepsy (Aura) 01/2019 - 12/2015
2	Seizures (Absence Seizure) 01/2019 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 07/2014 - 07/2011
1	TDP-43 Proteinopathies 01/2023
1	Iron Overload 01/2022
1	Parkinsonian Disorders (Parkinsonism) 11/2020
1	Movement Disorders (Movement Disorder) 11/2019
1	Neuroferritinopathy 11/2019
1	Multiple Sclerosis 01/2019
1	Stroke (Strokes) 01/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018
1	Disease Progression 01/2018
1	Synucleinopathies 12/2017
1	Intellectual Disability (Idiocy) 01/2017
1	Cognitive Dysfunction 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2016
1	Neuroinflammatory Diseases 03/2015
1	Acidosis 03/2015

3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
3	IronIBA 05/2020 - 10/2016
1	RNA Precursors (Precursor, mRNA)IBA 01/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023
1	Coenzyme A (CoA)IBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 11/2020
1	CalciumIBA 05/2020
1	ApoferritinsIBA 11/2019
1	Kainic Acid (Kainate)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Synapsins (Synapsin I)IBA 01/2018
1	SynucleinsIBA 12/2017
1	GDP dissociation inhibitor 1IBA 01/2017
1	gabazineIBA 01/2017
1	diminazene aceturateIBA 03/2015

2	Therapeutics 10/2016 - 03/2015
2	Transplantation 12/2015 - 07/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2014